Mallinckrodt Pharmaceuticals And Medtronic, Inc. Announce Clinical And Commercial Collaboration

Published: Jan 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. LOUIS, Mo.--(BUSINESS WIRE)--Mallinckrodt (NYSE: MNK) announced today that it has entered into a multiyear agreement with Medtronic (NYSE: MDT) to advance availability in the U.S. of intrathecal therapeutics for the treatment of chronic pain and severe spasticity.

Help employers find you! Check out all the jobs and post your resume.

Back to news